1 Introduction to Research & Analysis Reports
    1.1 Targeted Drugs for NSCLC Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Targeted Drugs for NSCLC Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Targeted Drugs for NSCLC Overall Market Size
    2.1 Global Targeted Drugs for NSCLC Market Size: 2021 VS 2028
    2.2 Global Targeted Drugs for NSCLC Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Targeted Drugs for NSCLC Players in Global Market
    3.2 Top Global Targeted Drugs for NSCLC Companies Ranked by Revenue
    3.3 Global Targeted Drugs for NSCLC Revenue by Companies
    3.4 Top 3 and Top 5 Targeted Drugs for NSCLC Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Targeted Drugs for NSCLC Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Targeted Drugs for NSCLC Players in Global Market
        3.6.1 List of Global Tier 1 Targeted Drugs for NSCLC Companies
        3.6.2 List of Global Tier 2 and Tier 3 Targeted Drugs for NSCLC Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Targeted Drugs for NSCLC Market Size Markets, 2021 & 2028
        4.1.2 Target EGFR
        4.1.3 Target ALK
        4.1.4 Target HER2
        4.1.5 Target ROS1
        4.1.6 Target BRAF
        4.1.7 Target MEK
        4.1.8 Target VEGFR2
        4.1.9 Target VEGF
        4.1.10 Target MET
    4.2 By Type - Global Targeted Drugs for NSCLC Revenue & Forecasts
        4.2.1 By Type - Global Targeted Drugs for NSCLC Revenue, 2017-2022
        4.2.2 By Type - Global Targeted Drugs for NSCLC Revenue, 2023-2028
        4.2.3 By Type - Global Targeted Drugs for NSCLC Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Targeted Drugs for NSCLC Market Size, 2021 & 2028
        5.1.2 Squamous Cell Carcinoma of NSCLC
        5.1.3 Adenocarcinoma of NSCLC
        5.1.4 Large Cell Carcinoma of NSCLC
    5.2 By Application - Global Targeted Drugs for NSCLC Revenue & Forecasts
        5.2.1 By Application - Global Targeted Drugs for NSCLC Revenue, 2017-2022
        5.2.2 By Application - Global Targeted Drugs for NSCLC Revenue, 2023-2028
        5.2.3 By Application - Global Targeted Drugs for NSCLC Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Targeted Drugs for NSCLC Market Size, 2021 & 2028
    6.2 By Region - Global Targeted Drugs for NSCLC Revenue & Forecasts
        6.2.1 By Region - Global Targeted Drugs for NSCLC Revenue, 2017-2022
        6.2.2 By Region - Global Targeted Drugs for NSCLC Revenue, 2023-2028
        6.2.3 By Region - Global Targeted Drugs for NSCLC Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Targeted Drugs for NSCLC Revenue, 2017-2028
        6.3.2 US Targeted Drugs for NSCLC Market Size, 2017-2028
        6.3.3 Canada Targeted Drugs for NSCLC Market Size, 2017-2028
        6.3.4 Mexico Targeted Drugs for NSCLC Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Targeted Drugs for NSCLC Revenue, 2017-2028
        6.4.2 Germany Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.3 France Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.4 U.K. Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.5 Italy Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.6 Russia Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.7 Nordic Countries Targeted Drugs for NSCLC Market Size, 2017-2028
        6.4.8 Benelux Targeted Drugs for NSCLC Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Targeted Drugs for NSCLC Revenue, 2017-2028
        6.5.2 China Targeted Drugs for NSCLC Market Size, 2017-2028
        6.5.3 Japan Targeted Drugs for NSCLC Market Size, 2017-2028
        6.5.4 South Korea Targeted Drugs for NSCLC Market Size, 2017-2028
        6.5.5 Southeast Asia Targeted Drugs for NSCLC Market Size, 2017-2028
        6.5.6 India Targeted Drugs for NSCLC Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Targeted Drugs for NSCLC Revenue, 2017-2028
        6.6.2 Brazil Targeted Drugs for NSCLC Market Size, 2017-2028
        6.6.3 Argentina Targeted Drugs for NSCLC Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Targeted Drugs for NSCLC Revenue, 2017-2028
        6.7.2 Turkey Targeted Drugs for NSCLC Market Size, 2017-2028
        6.7.3 Israel Targeted Drugs for NSCLC Market Size, 2017-2028
        6.7.4 Saudi Arabia Targeted Drugs for NSCLC Market Size, 2017-2028
        6.7.5 UAE Targeted Drugs for NSCLC Market Size, 2017-2028
7 Players Profiles
    7.1 Allergan
        7.1.1 Allergan Corporate Summary
        7.1.2 Allergan Business Overview
        7.1.3 Allergan Targeted Drugs for NSCLC Major Product Offerings
        7.1.4 Allergan Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.1.5 Allergan Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Targeted Drugs for NSCLC Major Product Offerings
        7.2.4 Amgen Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 ARIAD Pharmaceuticals (Takeda)
        7.3.1 ARIAD Pharmaceuticals (Takeda) Corporate Summary
        7.3.2 ARIAD Pharmaceuticals (Takeda) Business Overview
        7.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Major Product Offerings
        7.3.4 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.3.5 ARIAD Pharmaceuticals (Takeda) Key News
    7.4 Beacon Pharma Limited
        7.4.1 Beacon Pharma Limited Corporate Summary
        7.4.2 Beacon Pharma Limited Business Overview
        7.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Major Product Offerings
        7.4.4 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.4.5 Beacon Pharma Limited Key News
    7.5 BeiGene
        7.5.1 BeiGene Corporate Summary
        7.5.2 BeiGene Business Overview
        7.5.3 BeiGene Targeted Drugs for NSCLC Major Product Offerings
        7.5.4 BeiGene Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.5.5 BeiGene Key News
    7.6 Biocon
        7.6.1 Biocon Corporate Summary
        7.6.2 Biocon Business Overview
        7.6.3 Biocon Targeted Drugs for NSCLC Major Product Offerings
        7.6.4 Biocon Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.6.5 Biocon Key News
    7.7 Boehringer-Ingelheim
        7.7.1 Boehringer-Ingelheim Corporate Summary
        7.7.2 Boehringer-Ingelheim Business Overview
        7.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Major Product Offerings
        7.7.4 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.7.5 Boehringer-Ingelheim Key News
    7.8 Celgene Corporation
        7.8.1 Celgene Corporation Corporate Summary
        7.8.2 Celgene Corporation Business Overview
        7.8.3 Celgene Corporation Targeted Drugs for NSCLC Major Product Offerings
        7.8.4 Celgene Corporation Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.8.5 Celgene Corporation Key News
    7.9 Drug International Limted
        7.9.1 Drug International Limted Corporate Summary
        7.9.2 Drug International Limted Business Overview
        7.9.3 Drug International Limted Targeted Drugs for NSCLC Major Product Offerings
        7.9.4 Drug International Limted Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.9.5 Drug International Limted Key News
    7.10 Fujifilm Kyowa Kirin Biologics
        7.10.1 Fujifilm Kyowa Kirin Biologics Corporate Summary
        7.10.2 Fujifilm Kyowa Kirin Biologics Business Overview
        7.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Major Product Offerings
        7.10.4 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.10.5 Fujifilm Kyowa Kirin Biologics Key News
    7.11 Genvio Pharma Limited
        7.11.1 Genvio Pharma Limited Corporate Summary
        7.11.2 Genvio Pharma Limited Business Overview
        7.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Major Product Offerings
        7.11.4 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.11.5 Genvio Pharma Limited Key News
    7.12 Hetero Drugs
        7.12.1 Hetero Drugs Corporate Summary
        7.12.2 Hetero Drugs Business Overview
        7.12.3 Hetero Drugs Targeted Drugs for NSCLC Major Product Offerings
        7.12.4 Hetero Drugs Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.12.5 Hetero Drugs Key News
    7.13 ImClone Systems ‎(Eli Lilly)
        7.13.1 ImClone Systems ‎(Eli Lilly) Corporate Summary
        7.13.2 ImClone Systems ‎(Eli Lilly) Business Overview
        7.13.3 ImClone Systems ‎(Eli Lilly) Targeted Drugs for NSCLC Major Product Offerings
        7.13.4 ImClone Systems ‎(Eli Lilly) Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.13.5 ImClone Systems ‎(Eli Lilly) Key News
    7.14 Incepta Pharmaceuticals
        7.14.1 Incepta Pharmaceuticals Corporate Summary
        7.14.2 Incepta Pharmaceuticals Business Overview
        7.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Major Product Offerings
        7.14.4 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.14.5 Incepta Pharmaceuticals Key News
    7.15 Mylan
        7.15.1 Mylan Corporate Summary
        7.15.2 Mylan Business Overview
        7.15.3 Mylan Targeted Drugs for NSCLC Major Product Offerings
        7.15.4 Mylan Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.15.5 Mylan Key News
    7.16 Novartis
        7.16.1 Novartis Corporate Summary
        7.16.2 Novartis Business Overview
        7.16.3 Novartis Targeted Drugs for NSCLC Major Product Offerings
        7.16.4 Novartis Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.16.5 Novartis Key News
    7.17 Pfizer
        7.17.1 Pfizer Corporate Summary
        7.17.2 Pfizer Business Overview
        7.17.3 Pfizer Targeted Drugs for NSCLC Major Product Offerings
        7.17.4 Pfizer Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.17.5 Pfizer Key News
    7.18 Reliance Lifesciences
        7.18.1 Reliance Lifesciences Corporate Summary
        7.18.2 Reliance Lifesciences Business Overview
        7.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Major Product Offerings
        7.18.4 Reliance Lifesciences Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.18.5 Reliance Lifesciences Key News
    7.19 Roche
        7.19.1 Roche Corporate Summary
        7.19.2 Roche Business Overview
        7.19.3 Roche Targeted Drugs for NSCLC Major Product Offerings
        7.19.4 Roche Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.19.5 Roche Key News
    7.20 AstraZeneca
        7.20.1 AstraZeneca Corporate Summary
        7.20.2 AstraZeneca Business Overview
        7.20.3 AstraZeneca Targeted Drugs for NSCLC Major Product Offerings
        7.20.4 AstraZeneca Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.20.5 AstraZeneca Key News
    7.21 Cipla
        7.21.1 Cipla Corporate Summary
        7.21.2 Cipla Business Overview
        7.21.3 Cipla Targeted Drugs for NSCLC Major Product Offerings
        7.21.4 Cipla Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.21.5 Cipla Key News
    7.22 Teva
        7.22.1 Teva Corporate Summary
        7.22.2 Teva Business Overview
        7.22.3 Teva Targeted Drugs for NSCLC Major Product Offerings
        7.22.4 Teva Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.22.5 Teva Key News
    7.23 OSI Pharmaceuticals
        7.23.1 OSI Pharmaceuticals Corporate Summary
        7.23.2 OSI Pharmaceuticals Business Overview
        7.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Major Product Offerings
        7.23.4 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.23.5 OSI Pharmaceuticals Key News
    7.24 Glenmark Pharmaceuticals
        7.24.1 Glenmark Pharmaceuticals Corporate Summary
        7.24.2 Glenmark Pharmaceuticals Business Overview
        7.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Major Product Offerings
        7.24.4 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.24.5 Glenmark Pharmaceuticals Key News
    7.25 Natco Pharma
        7.25.1 Natco Pharma Corporate Summary
        7.25.2 Natco Pharma Business Overview
        7.25.3 Natco Pharma Targeted Drugs for NSCLC Major Product Offerings
        7.25.4 Natco Pharma Targeted Drugs for NSCLC Revenue in Global Market (2017-2022)
        7.25.5 Natco Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer